A detailed history of Profund Advisors LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Profund Advisors LLC holds 12,661 shares of PRTA stock, worth $192,700. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,661
Previous 18,073 29.95%
Holding current value
$192,700
Previous $373,000 43.43%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$16.73 - $24.79 $90,542 - $134,163
-5,412 Reduced 29.95%
12,661 $211,000
Q2 2024

Aug 13, 2024

SELL
$19.54 - $26.15 $562,849 - $753,250
-28,805 Reduced 61.45%
18,073 $373,000
Q1 2024

May 08, 2024

BUY
$24.75 - $40.66 $324,819 - $533,621
13,124 Added 38.88%
46,878 $1.16 Million
Q4 2023

Feb 14, 2024

BUY
$32.31 - $52.32 $230,047 - $372,518
7,120 Added 26.73%
33,754 $1.23 Million
Q3 2023

Nov 13, 2023

BUY
$47.3 - $70.6 $216,870 - $323,701
4,585 Added 20.79%
26,634 $1.29 Million
Q2 2023

Aug 10, 2023

SELL
$48.26 - $78.59 $216,301 - $352,240
-4,482 Reduced 16.89%
22,049 $1.51 Million
Q1 2023

May 11, 2023

BUY
$46.97 - $58.27 $1.25 Million - $1.55 Million
26,531 New
26,531 $1.29 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.